Drug Shortage Report for CARBOLITH

Last updated on 2019-08-01 History
Report ID 87750
Drug Identification Number 02011239
Brand name CARBOLITH
Common or Proper name CARBOLITH
Company Name BAUSCH HEALTH, CANADA INC.
Market Status MARKETED
Active Ingredient(s) LITHIUM CARBONATE
Strength(s) 600MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 100
ATC code N05AN
ATC description ANTIPSYCHOTICS
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2019-06-25
Estimated end date
Actual end date 2019-07-15
Shortage status Resolved
Updated date 2019-08-01
Company comments awaiting QA final release to market
Health Canada comments
Tier 3 Status No
Contact Address 2150 BOUL. ST-ELZEAR OUEST
LAVAL, QUEBEC
CANADA H7L 4A8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2019-08-01 French Compare
v3 2019-08-01 English Compare
v2 2019-06-27 French Compare
v1 2019-06-27 English Compare

Showing 1 to 4 of 4